From the Focused Ultrasound Surgery Foundation & Fibroid ReliefA new research center for MR-guided focused ultrasound ablation at the University of Virginia is aiming to become a leader in translational and clinical research for emerging interventional procedures.
A new research center for MR-guided focused ultrasound ablation at the University of Virginia is aiming to become a leader in translational and clinical research for emerging interventional procedures.
"The University is proud to be a partner in helping to turn a ‘big idea' into a world-class facility," said Dr. Tim Garson, provost at the University of Virginia, speaking before dedication ceremonies Sept 14. "This will become the leading center for translational research, education, and patient care in the new and rapidly evolving field of MR-guided focused ultrasound."
Focused ultrasound uses MRI guidance to direct multichannel ultrahigh frequency ultrasound to ablate tumors and treat other conditions as an alternative to open surgery or radiation therapy.
The UVA Center will initially offer uterine fibroid therapy, the first application of the focused ultrasound technology to receive FDA approval. In the future, it will also host clinical trials on uterine fibroids and fertility; Parkinson's disease and epilepsy; liver, brain, breast, and prostate tumors; and pain from bony metastasis.
Together, the state of Virginia and the Focused Ultrasound Surgery Foundation covered $7.1 million of the $8 million cost of establishing the institute. Other contributors included GE Healthcare, which manufactures ultrasound and MRI systems, and InSightec, an ultrasound equipment maker.
The center is designed to encourage collaboration between scientists and physicians in biomedical engineering, neurosurgery, surgery, radiology, cardiology, radiation oncology, neurology, urology, and gynecology. Potential applications include:
"The mission of the foundation is to develop new applications and to accelerate the worldwide adoption of focused ultrasound," said Dr. Neal Kassell, UVA professor of neurosurgery. "By creating a center of excellence we can make this happen sooner-and thereby reduce the death, disability, and suffering of untold numbers of patients."
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.